Glucocorticosteroid in treatment of severe pneumonia

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Ariani, Felinda ^a   Liu, Kaixiong ^b   Jing, Zhang ^a   Qu, Jieming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID;

ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; IMMUNOLOGY; INFLUENZA; PHYSIOLOGY; PNEUMONIA; REVIEW; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME;

CYTOKINES; GLUCOCORTICOIDS; HUMANS; INFLUENZA, HUMAN; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84893868725     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/865635     Document Type: Review

References (92)

1. WHO, The Top 10 Causes of Death 2013
2. WHO, The Top 10 Causes of Death 2013 (Pubitemid 30408719)
3. Kellum J. A., Kong L., Fink M. P., Weissfeld L. A., Yealy D. M., Pinsky M. R., Fine J., Krichevsky A., Delude R. L., Angus D. C., Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Archives of Internal Medicine 2007 167 15 1655 1663 2-s2.0-34548022149 10.1001/archinte.167.15.1655 (Pubitemid 47280347)
4. Dellinger R. P., Steroid therapy of septic shock: the decision is in the eye of the beholder. Critical Care Medicine 2008 36 6 1987 1989 2-s2.0-45149084684 10.1097/CCM.0b013e31817d7ee4
5. McGee S., Hirschmann J., Use of corticosteroids in treating infectious diseases. Archives of Internal Medicine 2008 168 10 1034 1046 2-s2.0-44349091001 10.1001/archinte.168.10.1034 (Pubitemid 351749220)
6. Schumer W., Steroids in the treatment of clinical septic shock. Annals of Surgery 1976 184 3 333 341 2-s2.0-0017064383
7. Carlet J., From mega to more reasonable doses of corticosteroids: a decade to recreate hope. Critical Care Medicine 1999 27 4 672 674 2-s2.0-0032939037 10.1097/00003246-199904000-00003 (Pubitemid 29218187)
8. Annane D., Raphael J. C., Gajdos P., Cook D., Steroid replacement in sepsis: an unexplored side of a multifaceted drug class. Critical Care Medicine 1996 24 5 899 900 2-s2.0-0029889310 10.1097/00003246-199605000-00035 (Pubitemid 26155742)
9. Briegel J., Kellermann W., Forst H., Haller M., Bittl M., Hoffmann G. E., Buchler M., Uhl W., Peter K., Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clinical Investigator 1994 72 10 782 787 2-s2.0-0028113787 (Pubitemid 24327776)
10. Moran J. L., Graham P. L., Rockliff S., Bersten A. D., Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Critical Care 2010 14 4, article R134 2-s2.0-77954409849 10.1186/cc9182
11. Minneci P. C., Deans K. J., Banks S. M., Eichacker P. Q., Natanson C., Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Annals of Internal Medicine 2004 141 1 47 56 2-s2.0-3042858950
12. Keh D., Sprung C. L., Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Critical Care Medicine 2004 32 11 S527 S533 2-s2.0-8444223102 10.1097/01.CCM.0000142983.15421.11 (Pubitemid 39489025)
13. Lee H.-S., Lee J. M., Kim M. S., Kim H. Y., Hwangbo B., Zo J. I., Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Annals of Thoracic Surgery 2005 79 2 405 410 2-s2.0-13244296861 10.1016/j.athoracsur.2004.07.079 (Pubitemid 40186527)
14. Meduri G. U., Golden E., Freire A. X., Taylor E., Zaman M., Carson S. J., Gibson M., Umberger R., Methylprednisolone infusion in early severe ards: results of a randomized controlled trial. Chest 2007 131 4 954 963 2-s2.0-34247231131 10.1378/chest.06-2100 (Pubitemid 46608692)
15. Meduri G. U., Chinn A. J., Leeper K. V., Wunderink R. G., Tolley E., Winer-Muram H. T., Khare V., Eltorky M., Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 1994 105 5 1516 1527 2-s2.0-0028228804 (Pubitemid 24152615)
16. Cronin L., Cook D. J., Carlet J., Heyland D. K., King D., Lansang M. A. D., Fisher C. J. Jr., Corticosteroid treatment for sepsis: a critical appraisal and meta- analysis of the literature. Critical Care Medicine 1995 23 8 1430 1439 2-s2.0-0029090390 10.1097/00003246-199508000-00019
17. Dellinger R. P., Levy Mitchell M., Andrew M. B., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 2013 41 2 580 637 10.1097/CCM. 0b013e31827e83af
18. Kellum J. A., Kong L., Fink M. P., Weissfeld L. A., Yealy D. M., Pinsky M. R., Fine J., Krichevsky A., Delude R. L., Angus D. C., Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Archives of Internal Medicine 2007 167 15 1655 1663 2-s2.0-34548022149 10.1001/archinte.167.15.1655 (Pubitemid 47280347)
19. Montón C., Torres A., El-Ebiary M., Filella X., Xaubet A., de la Bellacasa J. P., Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Critical Care Medicine 1999 27 9 1745 1753 2-s2.0-0032833710 10.1097/00003246-199909000-00008 (Pubitemid 29455099)
20. Hirao S., Wada H., Nakagaki K., Saraya T., Kurai D., Mikura S., Yasutake T., Higaki M., Yokoyama T., Ishii H., Nakata K., Aakashi T., Kamiya S., Goto H., Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunology and Medical Microbiology 2011 62 2 182 189 2-s2.0-79958831482 10.1111/j.1574-695X. 2011.00799.x
21. Alangari A. A., Genomic and non-genomic actions of glucocorticoids in asthma. Annals of Thoracic Medicine 2010 5 3 133 139 2-s2.0-77954859194 10.4103/1817-1737.65040
22. Vandevyver S., Dejager L., Tuckermann J., Libert C., New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 2013 154 3 993 1007 10.1210/en.2012-2045
23. Rhen T., Cidlowski J. A., Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. The New England Journal of Medicine 2005 353 16 1711 1723 2-s2.0-26844433194 10.1056/NEJMra050541 (Pubitemid 41464710)
24. Rano A., Carlos A., Oriol S., Antoni T., Associated inflammatory response in pneumonia: role of adjunctive therapy with glucocorticoids. Current Opinion in Infectious Diseases 2006 19 2 179 184 10.1097/01.qco.0000216629.51563.f8 (Pubitemid 44139148)
25. Snijders D., Daniels J. M. A., de Graaff C. S., van der Werf T. S., Boersma W. G., Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. American Journal of Respiratory and Critical Care Medicine 2010 181 9 975 982 2-s2.0-77952307234 10.1164/rccm.200905-0808OC
26. McDonough A. K., Curtis J. R., Saag K. G., The epidemiology of glucocorticoid-associated adverse events. Current Opinion in Rheumatology 2008 20 2 131 137 2-s2.0-40349092811 10.1097/BOR.0b013e3282f51031 (Pubitemid 351339883)
27. Kolditz M., Halank M., Schulte-Hubbert B., Höffken G., Adrenal function is related to prognosis in moderate community-acquired pneumonia. European Respiratory Journal 2010 36 3 615 621 2-s2.0-77956578386 10.1183/09031936.00191709
28. Gotoh S., Nishimura N., Takahashi O., Shiratsuka H., Horinouchi H., Ono H., Uchiyama N., Chohnabayashi N., Adrenal function in patients with community-acquired pneumonia. European Respiratory Journal 2008 31 6 1268 1273 2-s2.0-49649108549 10.1183/09031936.00135607
29. Meduri G. U., Yates C. R., Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Annals of the New York Academy of Sciences 2004 1024 24 53 2-s2.0-3042706511 10.1196/annals.1321.004 (Pubitemid 38879592)
30. Mesotten D., Vanhorebeek I., van den Berghe G., The altered adrenal axis and treatment with glucocorticoids during critical illness. Nature Clinical Practice Endocrinology and Metabolism 2008 4 9 496 505 2-s2.0-50049119061 10.1038/ncpendmet0921
31. Annane D., Bellissant E., Bollaert P. E., Briegel J., Keh D., Kupfer Y., Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. British Medical Journal 2004 329 7464 480 484 2-s2.0-4344618571 10.1136/bmj.38181.482222.55 (Pubitemid 39158891)
32. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulmé R., Lepage E., Le Gall J., Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Medicine 2002 28 2 108 121 2-s2.0-0036213966 10.1007/s00134-001-1143-z (Pubitemid 34293822)
33. Weitzman S., Berger S., Clinical trial design in studies of corticosteroids for bacterial infections. Annals of Internal Medicine 1974 81 1 36 42 2-s2.0-0016244155
34. Lefering R., Neugebauer E. A. M., Steroid controversy in sepsis and septic shock: a meta-analysis. Critical Care Medicine 1995 23 7 1294 1303 2-s2.0-0029036182 10.1097/00003246-199507000-00021
35. Minneci P. C., Deans K. J., Banks S. M., Eichacker P. Q., Natanson C., Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Annals of Internal Medicine 2004 141 1 47 56 2-s2.0-3042858950
36. Marik P., Kraus P., Sribante J., Havlik I., Lipman J., Johnson D. W., Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia: a randomized controlled study. Chest 1993 104 2 389 392 2-s2.0-0027257361 (Pubitemid 23229504)
37. Montón C., Ewig S., Torres A., El-Ebiary M., Filella X., Rañó A., Xaubet A., Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. European Respiratory Journal 1999 14 1 218 220 2-s2.0-0032863149 10.1034/j.1399-3003. 1999.14a37.x (Pubitemid 29411261)
38. Amado-Rodriguez L., Adrián G.-L., Inés L.-A., Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury. Respiratory Research 2013 14 1 52 10.1186/1465-9921-14-52
39. Yildiz O., Deganay M., Aygen B., Güven M., Keleştimur F., Tutuş A., Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Critical Care 2002 6 3 251 258 2-s2.0-0035998343 10.1186/cc1498 (Pubitemid 34679185)
40. Confalonieri M., Urbino R., Potena A., Piattella M., Parigi P., Puccio G., Della Porta R., Giorgio C., Blasi F., Umberger R., Meduri G. U., Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. American Journal of Respiratory and Critical Care Medicine 2005 171 3 242 248 2-s2.0-19944430688 10.1164/rccm.200406-808OC
41. Garcia-Vidal C., Calbo E., Pascual V., Ferrer C., Quintana S., Garau J., Effects of systemic steroids in patients with severe community-acquired pneumonia. European Respiratory Journal 2007 30 5 951 956 2-s2.0-38849127566 10.1183/09031936.00027607 (Pubitemid 351194800)
42. Meijvis S. C. A., Hardeman H., Remmelts H. H. F., Heijligenberg R., Rijkers G. T., Van Velzen-Blad H., Voorn G. P., Van De Garde E. M. W., Endeman H., Grutters J. C., Bos W. J. W., Biesma D. H., Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. The Lancet 2011 377 9782 2023 2030 2-s2.0-79958771376 10.1016/S0140-6736(11)60607-7
43. Mikami K., Suzuki M., Kitagawa H., Kawakami M., Hirota N., Yamaguchi H., Narumoto O., Kichikawa Y., Kawai M., Tashimo H., Arai H., Horiuchi T., Sakamoto Y., Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 2007 185 5 249 255 2-s2.0-34548569037 10.1007/s00408-007-9020-3 (Pubitemid 47397487)
44. Fernandez-Serrano S., Dorca J., Garcia-Vidal C., Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 2011 15 2, article R96 10.1186/cc10103
45. Salluh J. I. F., Póvoa P., Soares M., Castro-Faria-Neto H. C., Bozza F. A., Bozza P. T., The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Critical Care 2008 12 3, article R76 2-s2.0-45949084462 10.1186/cc6922 (Pubitemid 351891491)
46. Snijders D., Daniels J. M. A., de Graaff C. S., van der Werf T. S., Boersma W. G., Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. American Journal of Respiratory and Critical Care Medicine 2010 181 9 975 982 2-s2.0-77952307234 10.1164/rccm.200905-0808OC
47. Dehoux M. S., Boutten A., Ostinelli J., Seta N., Dombret M.-C., Crestani B., Deschenes M., Trouillet J.-L., Aubier M., Compartmentalized cytokine production within the human lung in unilateral pneumonia. American Journal of Respiratory and Critical Care Medicine 1994 150 3 710 716 2-s2.0-0028064312 (Pubitemid 24291499)
48. Annane D., Bellissant E., Bollaert P.-E., Briegel J., Confalonieri M., de Gaudio R., Keh D., Kupfer Y., Oppert M., Meduri G. U., Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. Journal of the American Medical Association 2009 301 22 2362 2375 2-s2.0-67049108021 10.1001/jama.2009.815
49. Keh D., Boehnke T., Weber-Cartens S., Schulz C., Ahlers O., Bercker S., Volk H.-D., Doecke W.-D., Falke K. J., Gerlach H., Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. American Journal of Respiratory and Critical Care Medicine 2003 167 4 512 520 2-s2.0-0037441670
50. Annane D., Sébille V., Charpentier C., Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Journal of the American Medical Association 2002 288 7 862 871 10.1001/jama.288.7.862
51. Oppert M., Ralf S., Claudia H., Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Critical Care Medicine 2005 33 11 2457 2464 10.1097/01.CCM.0000186370.78639.23 (Pubitemid 41682095)
52. Bollaert P.-E., Charpentier C., Levy B., Debouverie M., Audibert G., Larcan A., Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Critical Care Medicine 1998 26 4 645 650 2-s2.0-0031942028 10.1097/00003246-199804000-00010 (Pubitemid 28201409)
53. Kaufmann I., Briegel J., Schliephake F., Hoelzl A., Chouker A., Hummel T., Schelling G., Thiel M., Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Medicine 2008 34 2 344 349 2-s2.0-38849102945 10.1007/s00134-007-0868-8 (Pubitemid 351207639)
54. Annane D., Cavaillon J.-M., Corticosteroids in sepsis: from bench to bedside? Shock 2003 20 3 197 207 2-s2.0-0347054095
55. Sprung C. L., Annane D., Keh D., Hydrocortisone therapy for patients with septic shock. The New England Journal of Medicine 2008 358 2 111 124 10.1056/NEJMoa071366
56. Beigel J. H., Farrar J., Han A. M., Hayden F. G., Hyer R., De Jong M. D., Lochindarat S., Tien N. T. K., Hien N. T., Hien T. T., Nicoll A., Touch S., Yuen K.-Y., Avian influenza A (H5N1) infection in humans. The New England Journal of Medicine 2005 353 13 1374 1385 2-s2.0-25444432780 10.1056/NEJMra052211 (Pubitemid 41362705)
57. Confalonieri M., Cifaldi R., Dreas L., Viviani M., Biolo M., Gabrielli M., Methylprednisolone infusion for life-threatening H1N1-virus infection. Therapeutic Advances in Respiratory Disease 2010 4 4 233 237 2-s2.0-77955568664 10.1177/1753465810376951
58. Nicholls J. M., Poon L. L. M., Lee K. C., Ng W. F., Lai S. T., Leung C. Y., Chu C. M., Hui P. K., Mak K. L., Lim W., Yan K. W., Chan K. H., Tsang N. C., Guan Y., Yuen K. Y., Peiris J. S. M., Lung pathology of fatal severe acute respiratory syndrome. The Lancet 2003 361 9371 1773 1778 2-s2.0-0038024612 10.1016/S0140-6736(03)13413-7 (Pubitemid 36638425)
59. Wong C. K., Lam C. W. K., Wu A. K. L., Ip W. K., Lee N. L. S., Chan I. H. S., Lit L. C. W., Hui D. S. C., Chan M. H. M., Chung S. S. C., Sung J. J. Y., Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical and Experimental Immunology 2004 136 1 95 103 2-s2.0-12144285615 10.1111/j.1365-2249.2004.02415.x (Pubitemid 38437770)
60. Carter M. J., A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. Journal of Medical Microbiology 2007 56 7 875 883 2-s2.0-34447260688 10.1099/jmm.0.47124-0 (Pubitemid 47047478)
61. Kandun I. N., Wibisono H., Endang M. P. H., Three Indonesian clusters of H5N1 virus infection in 2005. The New England Journal of Medicine 2006 355 21 2186 2194 10.1056/NEJMoa060930 (Pubitemid 44791160)
62. Chokephaibulkit K., Uiprasertkul M., Puthavathana P., Chearskul P., Auewarakul P., Dowell S. F., Vanprapar N., A child with avian influenza A (H5N1) infection. Pediatric Infectious Disease Journal 2005 24 2 162 166 2-s2.0-13844280489 10.1097/01.inf.0000151037.25237.1e (Pubitemid 40250776)
63. Tran T. H., Thanh Liem N., Thi Dung N., Avian influenza A (H5N1) in 10 patients in Vietnam. The New England Journal of Medicine 2004 350 12 1179 1188 10.1056/NEJMoa040419 (Pubitemid 38339362)
64. Xu T., Qiao J., Zhao L., He G., Li K., Wang J., Tian Y., Wang H., Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. European Respiratory Journal 2009 33 4 852 860 2-s2.0-63849135869 10.1183/09031936.00130507
65. Brun-Buisson C., Richard J.-C. M., Mercat A., Thiébaut A. C. M., Brochard L., Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2011 183 9 1200 1206 2-s2.0-79955505106 10.1164/rccm.201101-0135OC
66. Quispe-Laime A. M., Bracco J. D., Barberio P. A., Campagne C. G., Rolfo V. E., Umberger R., Meduri G. U., H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Medicine 2010 36 1 33 41 2-s2.0-76549126643 10.1007/s00134-009-1727-6
67. Kudo K., Takasaki J., Manabe T., Uryu H., Yamada R., Kuroda E., Kobayashi N., Matsushita T., Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza a(H1N1)pdm09 in Japan. PLoS ONE 2012 7 2 2-s2.0-84857670111 10.1371/journal.pone.0032280 e32280
68. Roberts C., Nirmalan M., O'Shea S., Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). American Journal of Respiratory and Critical Care Medicine 2010 182 8 1089 1090 2-s2.0-78049341515
69. Kil H.-R., Lee J.-H., Lee K.-Y., Rhim J.-W., Youn Y.-S., Kang J.-H., Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Critical Care 2011 15 2, article 413 2-s2.0-79953005067 10.1186/cc10082
70. Liem N. T., Tung C. V., Hien N. D., Hien T. T., Chau N. Q., Long H. T., Hien N. T., Mai L. Q., Taylor W. R. J., Wertheim H., Farrar J., Khang D. D., Horby P., Clinical features of human influenza a (H5N1) infection in Vietnam: 2004-2006. Clinical Infectious Diseases 2009 48 12 1639 1646 2-s2.0-66949148008 10.1086/599031
71. Hien N. D., Ha N. H., Van N. T., Ha N. T. M., Lien T. T. M., Thai N. Q., Trang V. D., Shimbo T., Takahashi Y., Kato Y., Kawana A., Akita S., Kudo K., Human infection with highly pathogenic avian influenza virus (H5N1) in Northern Vietnam, 2004-2005. Emerging Infectious Diseases 2009 15 1 19 23 2-s2.0-58849083808 10.3201/eid1501.080073
72. Mady A., Ramadan O. S., Yousef A., Mandourah Y., Amr A. A., Kherallah M., Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia. Journal of Infection and Public Health 2012 5 1 52 56 2-s2.0-84857112460 10.1016/j.jiph.2011.10.005
73. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., Hernandez M., Quiñones-Falconi F., Bautista E., Ramirez-Venegas A., Rojas-Serrano J., Ormsby C. E., Corrales A., Higuera A., Mondragon E., Cordova-Villalobos J. A., Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. The New England Journal of Medicine 2009 361 7 680 689 2-s2.0-68149107226 10.1056/NEJMoa0904252
74. Abdel-Ghafar A.-N., Chotpitayasunondh T., Gao Z., Hayden F. G., Hien N. D., de Jong M. D., Naghdaliyev A., Peiris J. S. M., Shindo N., Soeroso S., Uyeki T. M., Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine 2008 358 3 220 273 2-s2.0-38349068756 10.1056/NEJMra0707279
75. Lee N., Hui D., Wu A., A major outbreak of severe acute respiratory syndrome in Hong Kong. The New England Journal of Medicine 2003 348 20 1986 1994 10.1056/NEJMoa030685 (Pubitemid 36569987)
76. Poutanen S. M., Donald M. P. H., Henry B., Identification of severe acute respiratory syndrome in Canada. The New England Journal of Medicine 2003 348 20 1995 2005 10.1056/NEJMoa030634 (Pubitemid 36569988)
77. Ho J. C., Ooi G. C., Mok T. Y., Chan J. W., Hung I., Lam B., Wong P. C., Li P. C., Ho P. L., Lam W. K., Ng C. K., Ip M. S., Lai K. N., Chan-Yeung M., Tsang K. W., High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. American Journal of Respiratory and Critical Care Medicine 2003 168 12 1449 1456 2-s2.0-9144258533 10.1164/rccm.200306-766OC (Pubitemid 38037328)
78. Jia W.-D., Deng X.-L., Tang X.-P., Yin C.-B., Zhang F.-C., Yang Z., Fang J.-Q., Dose of glucocorticosteroids in the treatment of severe acute respiratory syndrome. Nan Fang Yi Ke Da Xue Xue Bao 2009 29 11 2284 2287 2-s2.0-79953241513
79. Xu Y.-D., Jiang M., Chen R.-C., Fang J.-Q., Evaluation of the efficacy and safety of corticosteroid in the treatment of severe SARS in Guangdong province with multi-factor regression analysis. Chinese Critical Care Medicine 2008 20 2 84 87 2-s2.0-40349111436 (Pubitemid 351338115)
80. Chen R.-C., Tang X.-P., Tan S.-Y., Liang B.-L., Wan Z.-Y., Fang J.-Q., Zhong N., Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest 2006 129 6 1441 1452 2-s2.0-33745124335 10.1378/chest.129.6.1441 (Pubitemid 43894971)
81. Stockman L. J., Bellamy R., Garner P., SARS: systematic review of treatment effects. PLoS Medicine 2006 3 9 1525 1531 2-s2.0-33749019488 10.1371/journal.pmed.0030343 (Pubitemid 44455263)
82. Briel M., Boscacci R., Furrer H., Bucher H. C., Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC Infectious Diseases 2005 5, article 101 2-s2.0-27944449680 10.1186/1471-2334-5-101 (Pubitemid 41662731)
83. Patel N., Koziel H., Pneumocystis jiroveci pneumonia in adult patients with AIDS: treatment strategies and emerging challenges to antimicrobial therapy. Treatments in Respiratory Medicine 2004 3 6 381 397 2-s2.0-12744281062 10.2165/00151829-200403060-00005
84. Volkow P. F., Cornejo P., Zinser J. W., Ormsby C. E., Reyes-Terán G., Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome. AIDS 2008 22 5 663 665 2-s2.0-43149083477 10.1097/QAD.0b013e3282f4f223 (Pubitemid 351640603)
85. Fily F., Lachkar S., Thiberville L., Favennec L., Caron F., Pneumocystis jirovecii colonization and infection among non HIV-infected patients. Medecine et Maladies Infectieuses 2011 41 10 526 531 2-s2.0-80054011239 10.1016/j.medmal.2011.07.006
86. Roblot F., Godet C., le Moal G., Garo B., Faouzi Souala M., Dary M., de Gentile L., Gandji J., Guimard Y., Lacroix C., Roblot P., Becq-Giraudon B., Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. European Journal of Clinical Microbiology and Infectious Diseases 2002 21 7 523 531 2-s2.0-0036046406 10.1007/s10096-002-0758-5 (Pubitemid 35013591)
87. Yale S. H., Limper A. H., Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clinic Proceedings 1996 71 1 5 13 2-s2.0-0030061707 (Pubitemid 26021784)
88. Sepkowitz K. A., Pneumocystis carinii pneumonia among patients with neoplastic disease. Seminars in Respiratory Infections 1992 7 2 114 121 2-s2.0-0026480216
89. Schiff D., Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features. Journal of Neuro-Oncology 1996 27 3 235 240 2-s2.0-0029913191 10.1007/BF00165480 (Pubitemid 26098122)
90. Godeau B., Coutant-Perronne V., Du Le Thi Huong D. L. T. H., Guillevin L., Magadur G., De Bandt M., Dellion S., Rossert J., Rostoker G., Piette J.-C., Schaeffer A., Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. Journal of Rheumatology 1994 21 2 246 251 2-s2.0-0028213778 (Pubitemid 24078834)
91. Pareja J. G., Garland R., Koziel H., Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 1998 113 5 1215 1224 2-s2.0-0031925762 (Pubitemid 28223807)
92. Vogel M. N., Vatlach M., Weissgerber P., HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients. European Journal of Radiology 2012 81 6 1315 1320 10.1016/j.ejrad.2011.02.052